boldine has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| K, A; Kannan, P; Subramaniam, N; Thiruvengadam, D | 1 |
| Balaraman, G; Kannan, P; Krishnan, P; Mari, A; Salam, S; Subramaniam, N; Sundaram, J; Thiruvengadam, D; Velli, SK | 1 |
| Noureini, SK; Wink, M | 1 |
3 other study(ies) available for boldine and Liver Neoplasms
| Article | Year |
|---|---|
Hepatoprotective effect of boldine against diethylnitrosamine-induced hepatocarcinogenesis in wistar rats.
Topics: alpha-Fetoproteins; Animals; Antioxidants; Apoptosis; Aporphines; bcl-2-Associated X Protein; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Caspase 3; Cell Proliferation; Cytochromes c; Diethylnitrosamine; Liver; Liver Neoplasms; Male; Oxidative Stress; Peumus; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; RNA, Messenger; Weight Gain | 2019 |
Potential Chemopreventive Role of Boldine Against Hepatocellular Carcinoma via Modulation of Cell Cycle Proteins in Rat Model.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Aporphines; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Liver Neoplasms; Male; Rats | 2021 |
Dose-dependent cytotoxic effects of boldine in HepG-2 cells-telomerase inhibition and apoptosis induction.
Topics: Antioxidants; Apoptosis; Aporphines; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Liver Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telomerase | 2015 |